Short-term oral pentoxifylline use increases choroidal blood flow in patients with age-related macular degeneration

Archives of Ophthalmology

Volumn 116, Issue 1, 1998, Pages 27-30

  Kruger, Andreas ^a   Matiilla, Bettina ^b   Wolzt, Michael ^c   Pich, Stephan ^c   Streun, Karin ^a   Findl, Oliver ^b   Eichler, Hans Georg ^c   Schmetteret, Leopold ^c  

^a Departments of Clinical Pharmacology   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; CHOROID VASCULARIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EYE FUNDUS; FEMALE; HEMODYNAMICS; HUMAN; LASER DOPPLER FLOWMETRY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD FLOW; RETINA MACULA AGE RELATED DEGENERATION; VASCULAR RESISTANCE;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; CHOROID; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER-DOPPLER FLOWMETRY; MACULAR DEGENERATION; MALE; MIDDLE AGED; PENTOXIFYLLINE; RETINAL VESSELS; VASODILATOR AGENTS;

EID: 0031933398     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bressler NM, Bressler SB, Fine SL Age-related maculardegeneration. SurvOphthalmot. 1988:32:375-413.
2. Pauleikhoff D, Chen JC, Chisholm IH, Bird AC. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol. 1990:109:211-217.
3. Piguet B, Palmvang IB, Chisholm IH, Minassian D, Bird AC. Evolution of agerelated macular degeneration with choroidal perfusion abnormality. Am J Ophthalmol. 1992:113:657-663.
4. Friedman E, Krupsky S, Lane AM, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995:102:640-646.
5. Sonkin PL, Sinclair SH, Hatchell DL. The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity. Am J Ophthalmol. 1993; 115:775-780.
6. Schmetterer L, Kemmler D, Breiteneder H, et al. A randomized, placebo-controlled, double-blind cross-over study of the effect of pentoxifylline on ocular fundus pulsations. Am JOphthalmol. 1996:121:169-176.
7. Sonkin PL, Kelly LW, Sinclair SH, Hatchell DL. Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Arch Ophtha/mol. 1993; 111:1647-1652.
8. Sebag J, Tang M, Brown S, Sadun AA, Charles MA. Effects of pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy. Angiology. 1994; 45:429-433.
9. Wolf S, Arend O, Bertram B, et al. Hemodilution therapy in central retinal vein occlusion. GraelesArch Clin Exp Ophthalmol. 1994:232:33-39.
10. Kamphuis J, Smits P, Thien T. Vascular effects of pentoxifylline in humans. J Cardiovasc Pharmacol. 1994:26:648-654.
11. Ambrus JL, Anain JM, Anain SM, et al. Dose response effects of pentoxifylline on erythrocyte filterability: clinical and animal studies. Clin Pharmacol Ther. 1990; 48:50-56.
12. Sonkin PL, Freedman SF, Needham D, Rao KMK, Hatchell DL Pentoxifylline modulates deformability, F-actin content, and Superoxide anion production of polymorphonuclear leukocytes from diabetic cats. Exp Eye Res. 1992:55:831-838.
13. Schmetterer L, Lexer F, Unfried C, Sattmann H, Fercher A. Topical measurement of fundus pulsations. OptEng. 1995:34:711-716
14. Schmetterer L, Wolzt M, Salomon A, et al. The effect of isoproterenol, phenylephrine and sodium nitroprusside on fundus pulsations in healthy volunteers. Br J Ophthalmol. 1996;80:217-223.
15. Riva CE, Harino S, Petrig BL, Shonat RD. Laser Doppler flowmetry in the optic nerve. Exp Eye Res. 1992:55:499-506.
16. Michelson G, Langhans MJ, Groh MJM. Clinical investigation of the combination of a scanning laser ophthalmoscope and laser Doppler flowmeter. Cer J Ophthalmol. 1995:4:342-349.
17. Michelson G, Schmauss B, Langhans MJ, Harazny J, Groh MJM. Principle, validity, and reliability of scanning laser Doppler flowmetry. J Glaucoma. 1996:5:99-105.
18. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in a Chesapeake Bay waterman. Arch Ophthalmol. 1989:107:847-852.
19. Drexler W, Hitzenberger CK, Satmann H, Fercher AF. Measurement of the thickness of fundus layers by partial coherence tomography. Opt Eng. 1995:34:701 -710.
20. Schmetterer L, Strenn K, Findl 0, et al. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Clin Pharmacol Ther. 1997;61:583-595.
21. Langham ME, Tomey K. A clinical procedure for the measurement of the ocular pulse-pressure relationship and the ophthalmic arterial pressure. Exp Eye Res. 1978:27:17-25.
22. Langham ME, Farrell RA, O'Brien V, Silver DM, Schilder P. Blood flow in the human eye. Acta Ophthalmol. 1989;67(suppl 191):9-13.
23. Schmetterer L, Wolzt M, Lexer F, et al. The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and the optic disc region. Exp Eye Res. 1995; 61:685-690.
24. Schmetterer L, Lexer F, Graselli U, Findl 0, Eichler HG, Wolzt M. The effect of different mixtures of 0; and C02 on ocular fundus pulsations. Exp Eye Res. 1996; 63:351-355.
25. Inhoffen W, Nüssgens Z. Rheological studies on patients with posterior subretinal neovascularization and exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1990;228:316-320.
26. 2. BrJ Ophtha/mol. 1997:81:360-364.
27. Ward A, Clissold SP. Pentoxifylline, a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987:34:50-97.
28. Beerman B, Ings R, Mansby J, Chamberlain J, Me Donald A. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther. 1985; 37:25-28.
29. Rames A, Poirier JM, LeCoz F, et al. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients. Clin Pharmacol Ther. 1990:47:354-359.